ERGO Insider Trading Activity and SEC Form 4 Filings
ERGO insider trading summary
No open-market insider purchases or sales of Entia Biosciences, Inc. (ERGO) have been reported on SEC Form 4 in the past 12 months.
Latest ERGO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 25, 2014 | Marvin S Md Hausman | President, CEO, Acting CFO | Buy | $649K (2,162,980 @ $0.30) |
| Sep 25, 2014 | Devin D. Andres | COO, VP, Sales and Marketing | Buy | $129K (429,640 @ $0.30) |
| Dec 17, 2013 | Devin D. Andres | COO, VP, Sales and Marketing | Buy | $20K (52,089 @ $0.38) |
| Dec 17, 2013 | Marvin S Md Hausman | President, CEO, Acting CFO | Buy | $24K (62,505 @ $0.38) |
| Jul 12, 2013 | Marvin S Md Hausman | President, CEO, Acting CFO | Buy | $50K (131,579 @ $0.38) |
| Jun 11, 2013 | Devin D. Andres | COO, VP, Sales and Marketing | Buy | $50K (131,579 @ $0.38) |
| Feb 26, 2007 | William T Comfort III | Director | Buy | $0 (46,210 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.